NASH / NAFLD Selective adipocyte loss of Angiopoietin-2 prompts female-specific obesity and metabolic syndrome
NASH / NAFLD Automated whole slide image analysis for a translational quantification of liver fibrosis
NASH / NAFLD Best Practices in Liver Biopsy Histologic Assessment for Nonalcoholic Steatohepatitis Clinical Trials: Expert Opinion
Paris Nash 2021NASH / NAFLDPoster DISTRIBUTION OF LIPID VESICLE SIZE AS POTENTIAL MARKER OF NAS SEVERITY: ASSESSMENT WITH MORPHOQUANT-NASH AND MRI
Paris Nash 2021NASH / NAFLD Time-efficient and Reliable Automated Liver Fibrosis Quantification in Preclinical Fibrosis Models using WSI
NASH / NAFLDPoster Follow-up of NAFLD/NASH progression using an automated histological image analysis
NASH / NAFLD Diet Reversal and Immune Modulation Show Key Role for Liver and Adipose Tissue T Cells in Murine Nonalcoholic Steatohepatitis
NASH / NAFLD Automated computerized image analysis for the user-independent evaluation of disease severity in preclinical models of NAFLD/NASH
NASH / NAFLD Exogenous PP2A inhibitor exacerbates the progression of nonalcoholic fatty liver disease via NOX2-dependent activation of miR21
